Reposted by Tim Stinear
We’re very excited about our hookworm anemia vaccine and hope it becomes the second licensed human parasitic disease vaccine after malaria and the first human parasitic worm vaccine
blogs.bcm.edu/2026/03/19/f...
blogs.bcm.edu
Experimental hookworm vaccine shows promising protection in phase 2 human trial
Hookworm infects an estimated 113 million people globally primarily in sub-Saharan Africa, Southeast Asia, and South America. It is a major cause of iron-deficiency anemia in children and pregnant wom...
